autoimmune lymphoproliferative syndrome type 1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)	autoimmune disease, autoimmune lymphoproliferative syndrome type 1, immune system disorder	Recruiting	Not stated	2026-10-08		NCT00001350
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, autoimmune disease, autoimmune lymphoproliferative syndrome, autoimmune lymphoproliferative syndrome type 1, hereditary disease, hypersplenism, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, splenic disorder	Recruiting	Phase 2	2026-09-08		NCT06730126

Clinical trials